Trial Profile
A phase I, open-label, drug-drug interaction (DDI) trial investigating elafibranor and simvastatin in healthy participants
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Dec 2023
Price :
$35
*
At a glance
- Drugs Elafibranor (Primary) ; Simvastatin
- Indications Primary biliary cirrhosis; Primary sclerosing cholangitis
- Focus Adverse reactions; Pharmacokinetics
- 14 Nov 2023 Results presented at The Liver Meeting 2023: 74th Annual Meeting of the American Association for the Study of Liver Diseases
- 14 Jan 2010 Results reported in a Genfit media release.
- 14 Jan 2010 New trial record.